Should I refer my pregnant patient with a prenatal ultrasound showing renal pelvis dilation to maternal‑fetal medicine (MFM)?

Referral Decision for Prenatal Renal Pelvis Dilation

Your decision to refer to maternal-fetal medicine depends on the severity classification of the urinary tract dilation (UTD): if the fetus has UTD A2-3 (increased-risk), refer to MFM for serial monitoring; if UTD A1 (low-risk), you can manage this with a single follow-up ultrasound after 32 weeks without MFM referral. 1

Risk Stratification Algorithm

The 2025 American Academy of Pediatrics guidelines provide clear thresholds based on gestational age at diagnosis 1:

Before 28 Weeks Gestation

• UTD A1 (Low-Risk): Only requires one follow-up ultrasound after 32 weeks' gestation 1
• UTD A2-3 (Increased-Risk): Requires serial ultrasounds every 4 weeks AND specialty consultation 1

After 28 Weeks Gestation

The classification uses the most concerning ultrasound finding to determine risk category 1:

• UTD A1: Isolated mild renal pelvis dilation without other concerning features
• UTD A2-3: Presence of ANY of the following:
  • Central or peripheral calyceal dilation 1
  • Ureteral dilation 1
  • Abnormal kidney parenchyma appearance or thickness 1
  • Bladder abnormalities 1
  • Unexplained oligohydramnios 1

Key Clinical Pitfall

A critical caveat: even if the anterior-posterior renal pelvis diameter (APD) falls within the UTD A1 range, the presence of peripheral calyceal dilation or any other concerning feature automatically upgrades the classification to UTD A2-3. 1 This is the most concerning abnormal finding rule that determines higher risk categorization.

MFM Referral Indications

Refer to MFM when 1:

• UTD A2-3 classification at any gestational age
• Need for serial ultrasounds every 4 weeks to monitor progression
• Multidisciplinary counseling required (MFM coordinates with pediatric urology and nephrology) 2

Prognosis Context

Understanding natural history helps frame discussions 3:

• Only 43% of second-trimester UTD persists into the third trimester 3
• Of cases with persistent third-trimester UTD, 45% have postnatal UTD 3
• Among all second-trimester diagnoses, only 2% ultimately require surgery 3
• The majority (76%) of postnatal UTD cases are transient and resolve spontaneously 3

Management Does Not Alter Delivery Timing

Importantly, renal pelvis dilation—regardless of severity—does not necessitate preterm delivery or change delivery timing. 4 This reassures both providers and patients that MFM referral is for monitoring and counseling, not for urgent intervention.

When MFM Referral Is NOT Needed

You can manage without MFM referral if 1:

• UTD A1 classification with isolated mild dilation
• No additional concerning features (normal calyces, ureters, bladder, parenchyma, amniotic fluid)
• Single follow-up ultrasound after 32 weeks shows resolution or persistent low-risk features

The postnatal evaluation (renal-bladder ultrasound after 48 hours of life) will still be needed regardless of prenatal resolution, as normal third-trimester imaging does not completely exclude significant urologic abnormalities 5.